A new trading day began on Tuesday, with ARS Pharmaceuticals Inc (NASDAQ: SPRY) stock price down -1.68% from the previous day of trading, before settling in for the closing price of $14.26. SPRY’s price has ranged from $7.55 to $18.51 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 59377.90% over the last five years. Meanwhile, its annual earnings per share averaged -1764.58%. With a float of $56.04 million, this company’s outstanding shares have now reached $97.95 million.
The firm has a total of 160 workers. Let’s measure their productivity. In terms of profitability, gross margin is 98.87%, operating margin of -3.46%, and the pretax margin is 9.29%.
ARS Pharmaceuticals Inc (SPRY) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of ARS Pharmaceuticals Inc is 42.88%, while institutional ownership is 50.64%. The most recent insider transaction that took place on Apr 07 ’25, was worth 615,075. In this transaction Director of this company sold 50,002 shares at a rate of $12.30, taking the stock ownership to the 210,346 shares. Before that another transaction happened on Apr 07 ’25, when Company’s Director proposed sale 50,002 for $12.30, making the entire transaction worth $615,051.
ARS Pharmaceuticals Inc (SPRY) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around -1764.58% per share during the next fiscal year.
ARS Pharmaceuticals Inc (NASDAQ: SPRY) Trading Performance Indicators
Here are ARS Pharmaceuticals Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 14.04. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 15.43. Likewise, its price to free cash flow for the trailing twelve months is 105.98.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.08, a number that is poised to hit -0.34 in the next quarter and is forecasted to reach -0.55 in one year’s time.
Technical Analysis of ARS Pharmaceuticals Inc (SPRY)
Analysing the last 5-days average volume posted by the [ARS Pharmaceuticals Inc, SPRY], we can find that recorded value of 0.97 million was lower than the volume posted last year of 1.57 million. As of the previous 9 days, the stock’s Stochastic %D was 42.32%. Additionally, its Average True Range was 0.81.
During the past 100 days, ARS Pharmaceuticals Inc’s (SPRY) raw stochastic average was set at 73.90%, which indicates a significant increase from 28.64% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 44.96% in the past 14 days, which was lower than the 65.45% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $12.77, while its 200-day Moving Average is $12.97. Now, the first resistance to watch is $14.34. This is followed by the second major resistance level at $14.67. The third major resistance level sits at $14.98. If the price goes on to break the first support level at $13.70, it is likely to go to the next support level at $13.39. Now, if the price goes above the second support level, the third support stands at $13.06.
ARS Pharmaceuticals Inc (NASDAQ: SPRY) Key Stats
With a market capitalization of 1.38 billion, the company has a total of 98,211K Shares Outstanding. Currently, annual sales are 89,150 K while annual income is 8,000 K. The company’s previous quarter sales were 86,580 K while its latest quarter income was 49,930 K.
